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Abstract
Purpose Many studies about bariatric surgery have analyzed the effect of sleeve gastrectomy (SG) on glucose improvement,
beta-cell mass, and islet size modification. The effects of SG on the other endocrine cells of the pancreas, such as the alpha-cell
population, and their regulatory mechanisms remain less studied.
Materials and Methods We focused our work on the changes in the alpha-cell population after SG in a healthy model of Wistar
rats. We measured alpha-cell mass, glucose tolerance, and insulin release after oral glucose tolerance tests and plasma glucagon
secretion patterns after insulin infusion. Three Wistar rat groups were employed: SG-operated, surgical control (Sham), and
fasting control.
Results The results obtained showed significant increases in the alpha-cell population after SG. The result was an increase in
beta-cell transdifferentiation; it was shown by some expressed molecules (the loss of expression of Pdx-1 and the increase in Arx
and Pax6 cells/mm2 of islet). The serum results were enhanced plasma glucagon secretion pattern after insulin infusion assays
and normal glucose tolerance and insulin release after OGTT.
Conclusion We concluded that SG leads to an expansion of the alpha-cell population, at expense of beta-cell; this expansion of
alpha-cells is related to transdifferentiation. Plasma glucose level was not affected due to an increased glucagon response.
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Introduction
Type 2 diabetes mellitus (T2DM) is an endocrine disease im-
plicating several cell types within the islets of the pancreas. A
large number of studies have focused on the beta-cell popula-
tion and insulin production after bariatric procedures. Many of
these studies focused on several hormones that were respon-
sible for beta-cell changes. The effect of glucagon-like peptide
1 (GLP-1) or ghrelin on insulin production and the protective
role of GLP-1 on beta-cell mass is well-known [1, 2]. In con-
trast, changes in the alpha-cell population and glucagon re-
lease have not been studied enough. Dysregulated glucagon
secretion has been implicated in hyperglycemia in patients
with type 2 diabetes [3]. A few studies have reported the effect
of enterohormones stimulating alpha-cell secretion of gluca-
gon, such as ghrelin [4], meanwhile GLP-1 suppressed this
release [5].
Otherwise, the capability of alpha-cells to transdifferentiate
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[6], but this beta-cell to alpha-cell transdifferentiation plastic-
ity implies long-term sustained hyperglycemia [7].
All these findings lead us to think about the changes in islet
architecture, focusing on the alpha-cell component and, there-
fore, the role of alpha-cells on the maintenance of glucose
homeostasis after an exceptionally stressful situation, such as
bariatric surgery. In this landscape is the controversial role of
oxidative stress factors after bariatric surgical procedures.
Prior studies have shown that oxidative stress inhibits the ac-
tivity of nuclear beta-cell transcription factors, such as Pdx-1.
Pdx-1 is a factor that primes the loss of beta-cell identity,
which induces alpha-cell genes [8].
Another interesting transcription factor is Pax6. Pax6
deletion implies the decrease of insulin production and
glucagon gene expression. Pax6 is downregulated in dia-
betic db/db mice [9]. Paradoxically, the disruption of insu-
lin signaling does not lead to alpha-cell hyperplasia in ro-
dent models. This disruption of insulin signaling results in
the transdifferentiation of a small subpopulation of alpha-
cells to beta-cells [10, 11]. Recently, Aristaless-related
gene homeobox (Arx) and DNA-methyltransferase 1
(Dnmt-1) have been reported as markers when alpha-cells
decrease. These markers promote the conversion of alpha-
cells to native beta-cells [12].
All of this seems to suggest a two-way path between beta-
cell and alpha-cell populations. Thus, we found an interesting
feature to study within the physiological modifications of the
endocrine pancreas after bariatric surgery. We decided to re-
produce the most common clinical bariatric surgery, the sleeve
gastrectomy (SG).We employed a healthyWistar rat model to
analyze the pancreatic islet architecture and changes in the
alpha-cell population. These changes in alpha-cells have been
related to other pancreatic endocrine cells. We studied the
glucose changes after SG, in order to clarify the role of
alpha-cells in any glycemic component of the improvement
in T2DM after bariatric surgery.
Research Design and Methods
Animals
Eighteen male Wistar rats, weighing 200–220 g and 10–11
weeks old, were provided and kept at the Experimentation and
Animal Production Service of University (SEPA). All animal
procedures were performed with the approval of the
University Committee for the Ethical Use and Care of
Experimental Animals. This committee ensured that the pro-
cedures in all experiments were performed in accordance with
the international relevant guidelines and regulations of animal
welfare.
Wistar rats were randomly divided into three groups:
fasting control (FC) (n = 6), surgical control (sham-operated,
Sham) (n = 6), and sleeve gastrectomy-operated (SG) (n = 6)
(Fig. 1.1). After surgery, the animals were stable for 12 weeks
before being sacrificed. The animals in the FG group (n = 6)
received the same perioperative fasting periods related to the
surgical protocol. The animals finished a 12-h presurgical and
a 12-h postsurgical fasting period, respectively. An intake
readaptation period followed the surgeries to normalize
fasting. This stage was established for the FG and surgical
groups. To evaluate the effect of bariatric surgery in animals,
we observed the weight gain of the animals every 2 days,
which was measured in grams (g).
Surgical Procedures
Surgical procedures were performed in anesthetized animals
with continuous inhalation of isoflurane 3% v/v (Isoflo,
Abbott 571329.8). The sham technique (Sham) (n = 6)
reproduced the surgical aggression on the intestinal tube but
finally maintained its integrity. A laparotomy of 5 cm in the
upper third of the abdomen, with an incision of approximately
3 cm in the middle area of the abdomen, was performed,
exposing the small bowel. The jejunum was transected 40-
cm distal to the angle of Treitz, and a terminus-terminus anas-
tomosis was performed. The abdominal layers were closed as
above. The abdominal muscular and skin layers were closed in
one layer using a continuous suturing technique.
A laparotomy of 5 cm in the upper third of the abdomen
(Fig. 1), through sectioning of the gastrosplenic ligament and
exposing the stomach (Fig. 1.3, 1.4), was performed on the
SG group (n = 6). Curved forceps were applied from the angle
of Hiss to the antrum (Fig. 1.5), resulting in a cylindrical
stomach approximately 0.5 cm in diameter. The stomach
was sectioned and most of the fundus, corpus at the greater
curvature, and antrumwere resected (Fig. 1.6). The cardia and
pylorus were preserved, as well as the lesser curvature (Fig.
1.7). In the SG group, the initial stomach volume was reduced
by approximately 20%. Thus, we reproduced the actual selec-
tive technique used in humans. The abdominal layers were
closed as above (Fig. 1.8, 1.9).
Oral Glucose Tolerance Test, Insulin, and Glucagon
Measurement
Four weeks after surgery, oral glucose tolerance tests
(OGTTs) were performed in the FG, Sham, and SG groups.
After a 12-h fasting period, 2 g/kg (20% v/v) glucose solution
was administered through an oral gavage. Glucose levels were
measured by glucometer (Glucocard G-Meter 1810, Menarini
Diagnostics, Italy) in blood samples obtained from the tails of
rats at 0, 30, 60, 90, and 120 min after administration of a
glucose solution. The results were expressed as glucose mg/
dl plasma.
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Additionally, 4 weeks after surgery insulin was measured
in blood samples from the tails of rats, every 15 min for 60
min, after administration of the glucose solution administra-
tion. For this, we used an ELISA kit (ALPCO Diagnostics,
Salem, NH) according to the manufacturer’s instructions. The
area under curve (AUC) was calculated by trapezoidal rule for
every parameter in the study.
Insulin Infusion Assays
Insulin infusion assays were performed 6 weeks after sur-
gery in every rat group, with a 1.0 U/kg intraperitoneal
insulin infusion. Glucose levels were measured in fasting
rats in each group every 10 min for 60 min after an insulin
infusion using a glucometer (Glucocard G-Meter 1810,
Menarini Diagnostics, Italy) in blood samples obtained
from the tails of rats. The results were expressed as glucose
mg/dl plasma.
The plasma glucagon concentration was measured in
fasting rats in each group every 10 min for 60 min after the
insulin infusion. The plasma was removed from the blood
samples obtained from the tails of rats, added to EDTA tubes
and centrifuged at 4000 x g for 15 min at 4 °C. Total glucagon
was assessed by an ELISA kit (Millipore-Merck, Merck
KGaA, Darmstadt, Germany) according to the manufacturer’s
instructions. The results were expressed as glucagon pg/ml
plasma.
Sacrifice and Pancreas Preparation
All animals were sacrificed 12 weeks after surgery by
isoflurane inhalation overdose. The pancreases were im-
mediately removed and fixed in Bouin’s solution overnight
at 4 °C. Later, the samples were dehydrated, embedded in
paraffin, and cut into serial 8-μm microtome sections.
Pancreas Immunostaining
In rehydrated sections of pancreas, the beta- and alpha-cell
populations were analyzed by immunostaining by using guin-
ea pig anti-insulin Ig G antibody (Sigma-Aldrich, St. Louis
MO, USA) and rabbit anti-glucagon IgG antibody (Abcam,
Cambridge CB4 OFL, UK). The alpha-cell proliferation ratio
was calculated by double immunostaining using anti-PCNA
IgG antibody (Abcam, Cambridge CB4 OFL, UK) and anti-
glucagon IgG antibody. The differentiation markers Arx, Pdx-
1, and Pax6 were also analyzed using rabbit anti-Arx IgG,
rabbit anti-PDX-1, and rabbit anti-Pax6 antibodies (Abcam,
Cambridge CB4 OFL, UK). Fluorescent secondary antibodies
Alexa 546 and 488 (Molecular Probes Inc. Eugene, OR, USA)
were used against the primary antibodies. DAPI was used to
counterstain the nuclei.
The alpha-cell proliferation ratio was quantified in 50 islets
per condition. The results were noted under randomized con-
ditions by a single investigator and expressed as number of
glucagon PCNA+ cells and glucagon+ cells/mm2 of islet area.
Pax6-, Arx-, and Pdx-1-positive cell numbers were evalu-
ated in four slices of whole pancreas per condition and
expressed as number of Pax6-, Arx-, or PDX-1-positive
cells/mm2 of pancreas.
Every histological parameter was measured and noted by a
single investigator using a fluorescence microscope with dig-
ital camera and image analysis Cell-D software (Olympus,
GmbH. Hamburg, Germany).
Statistical Analyses
Data were presented as the means ± SEM. For AUC, histo-
logical, and weight gain data analysis, one-way ANOVA
followed by Tukey’s/Bonferroni’s post hoc test was conduct-
ed using SPSS V21.0 software. Statistical significance was
accepted at P < 0.05.
Fig. 1 .2 Weight gain in fasting control (FC) rats (n = 6) (discontinuous
black line with circles), sham-operated (Sham) rats (n = 6) (solid black
line with squares), sleeve gastrectomy-operated (SG) rats (n = 6)
(discontinuous black line with triangles) is presented on the Y axis, as
grams (g). On the X axis, the survival period over 40 days is presented.




First, we measured weight gain in the FC, Sham, and SG
groups for 40 days after surgery (Fig. 1B). There were no
differences between any groups from the first day to the thirty
fourth day, but statistically significant differences appeared
between the FC and SG groups from the thirtieth day (P <
0.05) and from the thirty second day to the end of the survival
period (P < 0.01).
OGTT and Insulin Secretion
Four weeks after surgery, OGTTs were performed in the
FC, Sham, and SG groups. Similar curves were described
for the three groups. No significant differences between the
glucose tolerance patterns of the FC, Sham, and SG groups
were observed at any time (Fig. 2a). The AUC was calcu-
lated for the three groups, but no statistically significant
differences were found between the groups (Fig. 2b).
Normal glucose tolerance was confirmed in all groups 4
weeks after surgery.
Plasma insulin secretion was analyzed in the three
groups 4 weeks after surgery. Similar plasma insulin se-
cretion patterns were shown by the FC, Sham, and SG
groups, but no statistically significant differences were
noted (Fig. 2c). No statistically significant differences in
the AUCs for plasma insulin appeared between the groups
(Fig. 2d), which confirmed a normal plasma insulin
secretion.
Glucose and Glucagon Secretion Assay After Insulin
Infusion
We also tested the existence of changes in glucose and
glucagon plasma level patterns. These parameters were
assayed after insulin infusion. As Fig. 3a shows, statisti-
cally significant differences in the plasma glucose pattern
appeared between the SG and FC groups 30 min after
insulin infusion (P < 0.05). We found a significant in-
crease of plasma glucose secretion AUC in the SG group
compared to the FC and Sham groups (P < 0.05) (Fig.
3b).
Figure 3c shows the plasma glucagon release pattern
after insulin infusion. The plasma glucagon level of the
Fig. 2 aOral glucose tolerance tests (OGTTs) in fasting control (FC) rats
(discontinuous black line with circles), sham-operated (Sham) rats (solid
black line with squares), and sleeve gastrectomy-operated (SG) rats (dis-
continuous black line with triangles). Glucose levels are represented as
mg/dl in the Y axis versus time after glucose ingestion in the X axis.
Values are expressed as the mean ± SEM. b Area under curve (AUC)
values are presented as mg/dl min-1 in the Y axis, expressed as the mean ±
SEM (FC, 16312.5 ± 1007.53; Sham, 17430.0 ± 1360.89; SG, 17212.50
± 780.49). c Plasma insulin in fasting control (FC) rats (discontinuous
black line with circles), sham-operated (Sham) rats (solid black line with
squares), and sleeve gastrectomy-operated (SG) rats (discontinuous black
line with triangles). Plasma insulin levels are represented as μU/ml in the
Y axis versus time after glucose ingestion inminutes in the X axis. Values
were expressed as the mean ± SEM. d Area under curve (AUC) values
were presented as μU/ml min-1 in the Y axis and expressed as the mean ±
SEM (FC, 2631.50 ± 297.0; Sham, 2601.50 ± 247.50; SG, 2593 ±
322.05)
OBES SURG
SG group was significantly increased between 30 and
40 min after insulin infusion compared to the FC and
Sham groups (P < 0.05). The plasma glucagon AUC of
the SG group showed statistically significant differences
compare to the FC and Sham groups (P < 0.05) (Fig.
3d).
Histological Study
Twelve weeks after surgery, the beta- and alpha-cell
masses were evaluated in pancreas samples from the FC,
Sham, and SG rat groups. As Fig. 4a shows, no statistically
significant differences appeared between the beta-cell mass
values of the FC, Sham, and SG groups, but there were
statistically significant differences in the alpha-cell mass
values of the SG group compared to the FC and Sham
groups (P < 0.05) (Fig. 4b).
Alpha-Cell Proliferation Assay
No increase in the number of glucagon-secreting/PCNA-pos-
itive cells appeared in the SG group compared to the FC and
Sham groups (Fig. 5a).
PDX-1, Arx, and Pax6 Histological Study
Pdx-1 expression was analyzed in the pancreatic islet cells.
Figure 5B shows low levels of Pdx-1-positive islet cells in
the pancreas samples from the SG group compared with
the samples from the FC and Sham groups (P < 0.05).
A significantly higher number of Arx-positive islet cells
were found in the pancreas samples of the SG group but not
in the pancreas samples of the FC and Sham groups (Fig. 5c).
The number of Pax6-positive islet cells was measured in
the three groups (Fig. 5d). As Fig. 5c shows, an increased
number of Pax6-positive cells were found in the FC and
Fig. 3 a Glucose plasma level after insulin administration in fasting
control (FC) rats (discontinuous black line with circles), sham-operated
(Sham) rats (solid black line with squares), and sleeve gastrectomy-
operated (SG) rats (discontinuous black line with triangles). Glucose
levels were represented as mg/dl in the Y axis versus time after insulin
administration in the X axis. Values were expressed as the mean ± SEM
(#P < 0.05). b Area under curve (AUC) values were presented as mg/dl
min-1 in the Y axis and expressed as the mean ± SEM (*P < 0.05) (FC,
3833.5 ± 267.7; Sham, 3689.0 ± 344.0; SG, 4790.0 ± 338.65. cGlucagon
plasma levels after insulin administration in fasting control (FC) rats
(discontinuous black line with circles), sham-operated (Sham) rats (solid
black line with squares), and sleeve gastrectomy-operated (SG) rats (dis-
continuous black line with triangles). Plasma glucagon levels were rep-
resented as pg/ml in the Y axis versus time after insulin administration in
the X axis. Values were expressed as the mean ± SEM (#P < 0.05). d
Plasma glucagon area under curve (AUC) values were presented as pg/ml
min-1 in the Y axis and expressed as the mean ± SEM (*P < 0.05) (FC,
7347.5 ± 453.6; Sham, 7401.0 ± 447.0; SG, 9236.0 ± 494.90)
OBES SURG
Sham groups compared to the SG group, with a statistically
significant difference (P < 0.05).
Discussion
Our intention was to probe the alpha-cell changes after SG.
We followed three rat groups, two control groups, and one SG
group. Therefore, functional changes around surgeries were
measured before the sacrifice and pancreatic histological anal-
yses. With regard to the functional tests, initially, there was a
lower weight gain in the SG rats compared to both groups of
control rats (Fig. 1). No effects on glucose tolerance, plasma
insulin secretion, or OGTT were observed in SG rats (Fig. 2)
compared to both groups of control rats. These data can be
explained by a normal beta-cell mass, as it was found in the
rats 12 weeks after bariatric surgery (Fig. 4a). As this study
was performed in a healthy rat model, we must suppose a
normal insulin sensibility at the liver.
We also explored changes in plasma glucose and glucagon
profiles after insulin infusion in the SG and control groups 6
weeks after surgery. Surprisingly, significant differences were
found in the recovery of normal glucose plasma levels in the
SG rats after insulin infusion (Fig. 3a) compared to the control
groups. There was no reason to presume changes in the liver
insulin sensitivity of these healthy rats, so we only found an
explanation. We supposed a retrieval of normal glucose with
an increase in glucagon release after the insulin infusion test.
Similar results were reported by Gudbrandsen et al. in
humans, who found elevated plasma glucagon levels after
SG [13]. To confirm this, we analyzed plasma glucagon pro-
files after insulin infusion. A higher curve was observed in the
SG group compared to the FC and Sham groups, with an
increase in the AUC of the SG group compared to the FC
and Sham groups (Fig. 3b and c). These data confirmed a
modified plasma glucagon release pattern in SG rats, which
led us to think about a possible impact of SG surgery on the
alpha-cell population.
The analysis of pancreas slices of the three groups in-
dicated a statistically significant increase of alpha-cell
mass in the SG group compared to the FC and Sham
groups (P < 0.01) (Fig. 4b). This is supported by the
plastic capacity of the alpha-cell population described in
relation to different stress situations, such as pregnancy
[14], fasting periods [15], or liver resistance to glucagon
in mice [16 ] . The ana tomica l and func t i ona l
Fig. 4 Beta-cell mass in green (Alexa 488); DAPI-counterstained nuclei
in FC (4.1), Sham (4.2), and SG (4.3) pancreas samples. a Beta-cell mass
expressed in milligrams (mg) in the Y axis, as the mean ± SEM. Fasting
control (FC) rats (white bar), sham-operated rats (Sham) (striped bar), and
sleeve gastrectomy-operated (SG) rats (black bar). Data obtained were
FC, 13.46 ± 0.75; Sham, 14.43 ± 0.94; and SG, 14.38 ± 0.52. bAlpha-cell
mass expressed in milligrams (mg) in the Y axis as the mean ± SEM. (*P
< 0.05; **P < 0.01). Fasting control (FC) rats (white bar), sham-operated
(Sham) rats (striped bar), and sleeve gastrectomy-operated (SG) rats
(black bar). Data obtained were FC, 0.130 ± 0.008; Sham, 0.123 ±
0.016; and SG, 0.211 ± 0.015
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rearrangements of the gastric tract after SG might hold the
answer to this alpha-cell expansion. Supporting this idea,
several published works reported increased populations of
other pancreatic endocrine cells. Beta- or epsilon-cells
have been reported to be increased in others after bariatric
surgery, such as gastric bypass (RYGB) or even after SG,
in rodents and humans [17–19].
We tried to clarify this element. We analyzed the
alpha-cell proliferation ratio in SG rats and controls, but
no statistically significant difference was found (Fig. 5a).
These data led us to think about other possible expansion
mechanisms for the alpha-cell population. These cellular
mechanisms could be differentiation from ductal progen-
itors or transdifferentiation from other endocrine cell lin-
eages. The roles of a large number of transcription factors
in the maintenance of every islet endocrine cell phenotype
are well-known. On the basis of this, a recent study pro-
posed the conversion of beta-cells to alpha-cells in Fcor-
knockout mice (Fcor KO). This was due to Fcor inhibition
that drove an increase of Arx expression [20]. As a result,
we examined the expression of Arx in the pancreas sam-
ples of the three study groups.
Surprisingly, a high expression of Arx was found in
glucagon- and insulin-positive areas in the SG group com-
pared to the FC and Sham group, as Fig. 5c shows (P <
0.01). This result supports our hypothesis about beta-cell to
alpha-cell transdifferentiation after SG.
In addition, an increased number of Pax6-positive cells
were also found in the pancreatic islets of the SG group com-
pared to the FC and Sham groups (P < 0.05) (Fig. 5d). It is
well-known that the Pax6 homeodomain is required for nor-
mal alpha-cell development [21] and glucagon gene expres-
sion [22]. This reinforces our hypothesis regarding beta-cell to
alpha-cell transdifferentiation.
In opposition, no decrease in beta-cell mass was found
(Fig. 4a). This paradoxical finding could be partially ex-
plained by the short survival period from surgery to sacrifice.
Moreover, we focused on the results of the Pdx-1 transcription
factor. Pancreatic duodenal homeobox-1 (Pdx-1) has been
characterized as an insulin transcription factor, mostly restrict-
ed to beta-cells [8, 23]. In our findings, Pdx-1 showed low
expression in insulin-positive area of islets in SG pancreas
samples (P < 0.05) (Fig. 5b), which indicated beta-cell de-
differentiation, although a high number of beta-cells could
Fig. 5 a Alpha-cell proliferation expressed as number of PCNA+ cells/
mm2 of glucagon-positive area in the Y axis mean ± SEM. Fasting control
(FC) rats (white bar); sham-operated (Sham) rats (striped bar); and sleeve
gastrectomy-operated (SG) rats (black bar). Data obtained were FC, 4.81
± 0.77; Sham, 4.40 ± 1.06; SG, 5.01 ± 0.60. b Pdx-1 expression in beta-
cell area as Pdx-1+ cells/mm2 of insulin+ area in the Y axis, as the mean ±
SEM. Fasting control (FC) rats (white bar); sham-operated (Sham) rats
(striped bar); and sleeve gastrectomy-operated (SG) rats (black bar). cArx
expression in beta-cell area as Arx+ cells/mm2 of insulin+ area in the Y
axis, as the mean ± SEM. Fasting control (FC) rats (white bar); sham-
operated (Sham) rats (striped bar); and sleeve gastrectomy-operated (SG)
rats (black bar). d Pax6 expression in beta-cell area as Pax6+ cells/mm2 of
insulin+ area in the Y axis, as the mean ± SEM, in fasting control (FC)
rats (white bar); sham-operated rats (Sham) (striped bar); and sleeve
gastrectomy-operated (SG) rats (black bar)
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retain insulin granules in the cytoplasm. This would explain
persistent insulin staining and a similar beta-cell mass value in
the SG group compared to the FC and Sham groups.
On the other hand, a previous study has reported an in-
crease in the pancreatic epsilon-cell population in healthy rats
after SG [19]. This may be relevant in relation to the capacity
of ghrelin to stimulate glucagon secretion in humans as report-
ed by Broglio et al. [4]. This report was a previous conse-
quence of our recent findings.
Taken together, all the data suggest a complex landscape in
the pancreatic islets after SG. Thus, alpha-cell population ex-
pansion happens at the expense of the beta-cell population
through a transdifferentiation mechanism after SG.
However, preserved beta-cell mass allows for normal insulin
secretion and glucose tolerance, with enhanced glucagon re-
lease in response to hypoglycemia. Thus, this whole mecha-
nism supposes an integrated response to the functional chang-
es in glucose absorption after SG.
However, a large number of questions remain around these
findings, such as the exact mechanism that triggers these
changes in the islet after surgery. Otherwise, we must expect
that this transdifferentiation event can affect other islet endo-
crine populations, such as delta-cells. We must clarify how
this process affects long-term beta-cell mass and function.
All these questions should be studied in the future.
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